Core Laboratories Nv Stock Performance
| CLB Stock | USD 19.65 0.83 4.41% |
On a scale of 0 to 100, Core Laboratories holds a performance score of 9. The firm shows a Beta (market volatility) of 1.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Please check Core Laboratories' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Core Laboratories' price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Core Laboratories NV are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting essential indicators, Core Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.32) | Five Day Return (5.38) | Year To Date Return 11.03 | Ten Year Return (80.87) | All Time Return 527.33 |
Forward Dividend Yield 0.002 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.04 | Dividend Date 2025-11-24 |
1 | Core Laboratories Inc Q3 2025 Earnings Call Highlights Strong Revenue Growth and ... | 11/05/2025 |
2 | Core Laboratories Inc.s Stock Is Going Strong Is the Market Following Fundamentals | 11/13/2025 |
3 | What dividend safety rating applies to Core Laboratories Inc. stock - Trade Volume Report Real-Time Volume Surge Alerts - newser.com | 11/18/2025 |
4 | A Look At The Fair Value Of Core Laboratories Inc. | 11/21/2025 |
| Core Laboratories dividend paid on 24th of November 2025 | 11/24/2025 |
5 | Disposition of 864 shares by Sow Teo of Core Laboratories subject to Rule 16b-3 | 12/01/2025 |
6 | Disposition of 180722 shares by Lawrence Bruno of Core Laboratories subject to Rule 16b-3 | 12/31/2025 |
7 | CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL | 01/05/2026 |
8 | Will Core Laboratories Inc. stock attract more institutional investors - 2025 Retail Activity Long-Term Growth Portfolio Plans - ulpravda.ru | 01/08/2026 |
9 | HAL vs. CLB Which Stock Is the Better Value Option | 01/27/2026 |
| Begin Period Cash Flow | 15.1 M | |
| Total Cashflows From Investing Activities | -6.4 M |
Core Laboratories Relative Risk vs. Return Landscape
If you would invest 1,593 in Core Laboratories NV on October 31, 2025 and sell it today you would earn a total of 289.00 from holding Core Laboratories NV or generate 18.14% return on investment over 90 days. Core Laboratories NV is generating 0.308% of daily returns assuming volatility of 2.6494% on return distribution over 90 days investment horizon. In other words, 23% of stocks are less volatile than Core, and above 94% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Core Laboratories Target Price Odds to finish over Current Price
The tendency of Core Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 19.65 | 90 days | 19.65 | roughly 2.7 |
Based on a normal probability distribution, the odds of Core Laboratories to move above the current price in 90 days from now is roughly 2.7 (This Core Laboratories NV probability density function shows the probability of Core Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.81 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Core Laboratories will likely underperform. Additionally Core Laboratories NV has an alpha of 0.111, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Core Laboratories Price Density |
| Price |
Predictive Modules for Core Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Core Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Core Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Core Laboratories is not an exception. The market had few large corrections towards the Core Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Core Laboratories NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Core Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.11 | |
β | Beta against Dow Jones | 1.81 | |
σ | Overall volatility | 1.51 | |
Ir | Information ratio | 0.06 |
Core Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Core Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Core Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: HAL vs. CLB Which Stock Is the Better Value Option |
Core Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Core Stock often depends not only on the future outlook of the current and potential Core Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Core Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.7 M | |
| Cash And Short Term Investments | 19.2 M |
Core Laboratories Fundamentals Growth
Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Laboratories, and Core Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0497 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 1.06 B | ||||
| Shares Outstanding | 46.56 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 3.38 X | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 523.85 M | ||||
| Gross Profit | 103.23 M | ||||
| EBITDA | 73.27 M | ||||
| Net Income | 32.15 M | ||||
| Cash And Equivalents | 19.16 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 180.14 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.89 X | ||||
| Cash Flow From Operations | 56.39 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Market Capitalization | 882.54 M | ||||
| Total Asset | 590.41 M | ||||
| Retained Earnings | 150.28 M | ||||
| Working Capital | 129.02 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
About Core Laboratories Performance
By analyzing Core Laboratories' fundamental ratios, stakeholders can gain valuable insights into Core Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Core Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 44.81 | 27.79 | |
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.11 | 0.20 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.12 | 0.14 |
Things to note about Core Laboratories performance evaluation
Checking the ongoing alerts about Core Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: HAL vs. CLB Which Stock Is the Better Value Option |
- Analyzing Core Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Core Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Core Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Core Laboratories' stock. These opinions can provide insight into Core Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |